Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
GSK plc is a global biopharma company. The Company makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercia...
Data could not be retrieved
GS71 | Peers | Sector | |
---|---|---|---|
Market Cap | - | 0 K | - |
Price % of 52 Week High | - | 0.0% | - |
Dividend Yield | - | 0.0% | - |
Shareholder Yield | - | 0.0% | - |
1 Year Price Total Return | -10.5% | 0.0% | - |
Beta (5 Year) | - | 0.00 | - |
No data available
(EUR in thousands) | Trailing Twelve Months | Fiscal Quarters | |||
---|---|---|---|---|---|
Period Ending | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 |
Income Statement | |||||
Revenue | |||||
Operating Income | |||||
Net Profit | |||||
Diluted EPS | |||||
EBITDA | |||||
Balance Sheet | |||||
Cash & ST Invest. | |||||
Current Assets | |||||
Total Assets | |||||
Current Liabilities | |||||
Total Liabilities | |||||
Total Equity | |||||
Total Debt | |||||
Cash Flow Statement | |||||
Cash Flow Operations | |||||
Cash From Investing | |||||
Cash From Financing | |||||
Free Cash Flow | |||||